CIK 0001551152
- Large accelerated filer
AbbVie Inc.
Sign in to watch- Ticker
- ABBV
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 320375147
- Phone
- +1 847-932-7900
- Business address
- 1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, IL, 60064
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $11,925,738
- in 1 filing
Net −$11,925,738. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-15 | SALEKI-GERHARDT AZITA EVP, CHIEF OPERATIONS OFFICER | Grant or award · Option (Right to Buy) | +29,313 | 29,313 | ||
| 2024-02-15 | Donoghoe Nicholas EVP, CHIEF BUS/STRAT OFFICER | Grant or award | +22,657 | 78,560 | ||
| 2024-02-15 | Donoghoe Nicholas EVP, CHIEF BUS/STRAT OFFICER | Grant or award | +6,042 | 84,602 | ||
| 2024-02-15 | Donoghoe Nicholas EVP, CHIEF BUS/STRAT OFFICER | Grant or award | +4,520 | 89,122 | ||
| 2024-02-15 | Donoghoe Nicholas EVP, CHIEF BUS/STRAT OFFICER | Grant or award | +4,634 | 93,756 | ||
| 2024-02-15 | Donoghoe Nicholas EVP, CHIEF BUS/STRAT OFFICER | Grant or award · Option (Right to buy) | +21,433 | 21,433 | ||
| 2024-02-15 | Buckbee Kevin K SVP, CONTROLLER | Grant or award | +7,080 | 14,243 | ||
| 2024-02-15 | Buckbee Kevin K SVP, CONTROLLER | Grant or award | +1,888 | 16,131 | ||
| 2024-02-15 | Buckbee Kevin K SVP, CONTROLLER | Grant or award | +1,476 | 17,607 | ||
| 2024-02-15 | Buckbee Kevin K SVP, CONTROLLER | Grant or award | +1,604 | 19,211 | ||
| 2024-02-15 | Buckbee Kevin K SVP, CONTROLLER | Grant or award · Option (Right to buy) | +6,934 | 6,934 | ||
| 2024-02-15 | Thakkar Roopal SVP, CMO, GLOBAL THERAPEUTICS | Grant or award | +8,022 | 18,399 | ||
| 2024-02-15 | Thakkar Roopal SVP, CMO, GLOBAL THERAPEUTICS | Grant or award | +2,138 | 20,537 | ||
| 2024-02-15 | Thakkar Roopal SVP, CMO, GLOBAL THERAPEUTICS | Grant or award | +1,844 | 22,381 | ||
| 2024-02-15 | Thakkar Roopal SVP, CMO, GLOBAL THERAPEUTICS | Grant or award | +5,792 | 28,173 | ||
| 2024-02-15 | Thakkar Roopal SVP, CMO, GLOBAL THERAPEUTICS | Grant or award · Option (Right to buy) | +13,868 | 13,868 | ||
| 2024-02-15 | Siatis Perry C EVP, GC AND SECRETARY | Grant or award | +8,022 | 18,399 | ||
| 2024-02-15 | Siatis Perry C EVP, GC AND SECRETARY | Grant or award | +2,138 | 20,537 | ||
| 2024-02-15 | Siatis Perry C EVP, GC AND SECRETARY | Grant or award | +1,844 | 22,381 | ||
| 2024-02-15 | Siatis Perry C EVP, GC AND SECRETARY | Grant or award | +5,792 | 28,173 |
Page 17 of 23 · 457 trades